Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363320110320010113
Journal of Korean Oriental Internal Medicine
2011 Volume.32 No. 1 p.113 ~ p.120
Case Series of Advanced Non-Small Cell Lung Cancer Patients Treated with Hang-Am Plus
Zheng Hong-mei

Yoon Jeung-Won
Lee Yeon-Weol
Cho Chong-Kwan
Oh Dal-Seok
Abstract
Objectives: A case series was conducted to investigate the therapeutic effects of Hang-Am Plus (HAP) on the tumor response and HRQoL (Health Related Quality of Life) in advanced non-small cell lung cancer (NSCLC) patients.

Methods: Three patients were given 1,000-2,000 mg of HAP, three times a day (daily total dosage of 3,000-6,000 mg/day) for 12 weeks.

Results: After the 3 month administration with HAP, three patients showed stable disease (SD) condition according to the chest computed tomography (CT), and two of the patients reported a decrease in pain levels.

Conclusions : The observed NSCLC cases suggest treatment with HAP may be related to the observed tumor growth inhibition and pain reduction.
KEYWORD
Hang-Am Plus (HAP), Non Small Cell Lung Cancer (NSCLC), Oriental Medicine treatment, Stable Disease (SD)
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)